Enjoy complimentary customisation on priority with our Enterprise License!
The mrna synthesis raw material market size is forecast to increase by USD 776.45 million at a CAGR of 4.93% between 2023 and 2028.
The mrna synthesis raw material industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
MRNA synthesis raw materials have become essential components In the production of mRNA-based vaccines and therapeutics, revolutionizing the biopharmaceutical industry. MRNA technology enables rapid development and scalability of vaccines against various infectious diseases, including HIV, tuberculosis, and cancer. Key players, such as Thermo Fisher Scientific Inc., provide high-quality mRNA synthesis reagents and kits to vaccine manufacturers. These materials are indispensable for producing mRNA-1273 and other mRNA vaccines, enabling the synthesis of proteins for patient populations. Capping agents, nucleotide segments, and enzymatic capping are crucial aspects of mRNA synthesis, ensuring improved medical technology through flexible, durable, and immunogenic vaccines and medications.
Biopharmaceutical and pharmaceutical companies, CROs & CMOs, and research institutions rely on these raw materials for vaccine production and gene-editing therapies. The therapeutics segment, focusing on chronic diseases, benefits from mRNA technology, with healthcare professionals seeking high-quality raw materials for drug discovery and biotechnology companies developing nutraceuticals and diagnostics research. The nucleotide market segment, including nucleotide analogs, plays a significant role in mRNA synthesis, while capping enzymes and DNA templates are vital for therapeutics production. The use of mRNA synthesis raw materials advances medical technology, enabling the production of mRNA vaccines, medications, and gene therapies.
Get a glance at the mRNA Synthesis Raw Material Industry report of share of various segments Request Free Sample
The Vaccine production segment was valued at USD 1622.94 million in 2018 and showed a gradual increase during the forecast period.
Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions, Request Free Sample
The market in North America is experiencing significant growth due to the increasing focus on mRNA-based therapeutics, vaccines, and diagnostics. With numerous leading research institutions and biopharmaceutical companies based in North America, this region is at the forefront of mRNA innovation. The potential of mRNA technology to address various diseases, such as cancer, infectious diseases, and chronic conditions, has attracted substantial investment and research interest. Key factors driving the growth of the market include advancements in RNA technology, government funding initiatives, strategic collaborations, and a favorable regulatory environment. MRNA-based vaccines, such as mRNA-1273 for COVID-19, have demonstrated impressive results, further fueling market growth.
The demand for high-quality raw materials, including nucleotides, capping agents, and DNA templates, is crucial for mRNA synthesis processes. The therapeutics segment, including gene-editing therapies, also presents significant opportunities. Biopharmaceutical and pharmaceutical companies, CROs & CMOs, and contract service providers are key players In the market. The market is expected to grow further as mRNA technology continues to evolve, offering improved medical treatments and potential alternatives to traditional ones. Key players are investing in research and development, focusing on the production of flexible, durable, and immunogenic mRNA-based medications and vaccines. High-quality raw materials are essential to ensure the success of these endeavors, making the market a critical component of the biotechnology industry.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Growing prevalence of chronic and infectious diseases is the key driver of the market.
Collaborations in biotechnology and manufacturing processes related to mRNA synthesis is the upcoming market trend.
What challenges does the mRNA Synthesis Raw Material Industry face during its growth?
Complexity of mRNA synthesis and purification processes is a key challenge affecting the industry growth.
Exclusive Customer Landscape
The mrna synthesis raw material market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the mrna synthesis raw material market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, mrna synthesis raw material market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.
Bayer AG - The company specializes in supplying mRNA synthesis raw materials, including uridine mRNA, for the development of tumor type-specific, off-the-shelf therapies for cancer patients. These advanced treatments are particularly beneficial for those with hard-to-treat, advanced diseases. The mRNA synthesis raw materials enable the production of therapeutic proteins, which can help modulate gene expression and potentially offer effective treatments for various cancer types. The company's commitment to research and development ensures the delivery of high-quality, reliable raw materials to support the scientific community's ongoing efforts to create innovative cancer therapies.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
MRNA synthesis is a critical process In the production of mRNA-based therapeutics and vaccines. This technology, which involves the creation of artificial mRNA molecules to introduce new genetic material into cells, has gained significant attention due to its potential applications in various fields, including healthcare and biotechnology. The raw materials market for mRNA synthesis is a crucial component of this emerging industry. These materials include nucleotides, capping agents, and polymerases, among others. The nucleotide segment is a significant contributor to the market, as it provides the building blocks for mRNA synthesis. Nucleotide analogs, in particular, have gained popularity due to their ability to improve the stability and durability of mRNA molecules.
The demand for high-quality raw materials in mRNA synthesis is driven by the increasing focus on developing effective mRNA-based vaccines and therapeutics. The therapeutics segment, which includes applications for chronic diseases, cancer, and cardiovascular diseases, among others, is expected to experience significant growth In the coming years. The biopharmaceutical and pharmaceutical industries are major consumers of mRNA synthesis raw materials. These companies rely on contract service providers, such as CROs and CMOs, to produce the raw materials and conduct research and development activities. The use of mRNA technology in vaccine production has gained momentum in recent years, with several companies successfully bringing mRNA-based vaccines to market.
The research institutions and government agencies are also active players In the market. They invest heavily in research and development activities, focusing on improving the immunogenicity of mRNA-based vaccines and therapeutics. The use of enzymatic capping and cleancap technology, for instance, has been instrumental in enhancing the stability and efficacy of mRNA molecules. The market is expected to grow significantly In the coming years, driven by the increasing demand for mRNA-based vaccines and therapeutics. The market is highly competitive, with several biotechnology companies and nutraceutical companies entering the fray. The market dynamics are influenced by various factors, including technological advancements, regulatory frameworks, and market trends.
The use of mRNA technology in gene-editing therapies is another emerging application that is expected to drive the demand for mRNA synthesis raw materials. The flexibility and durability of mRNA molecules make them an attractive option for gene therapy applications, particularly In the treatment of chronic diseases. In conclusion, the market is a critical component of the emerging mRNA-based therapeutics and vaccines industry. The market is driven by the increasing demand for effective mRNA-based products, particularly In the therapeutics and vaccine production sectors. The use of high-quality raw materials, such as nucleotides, capping agents, and polymerases, is essential for producing effective and stable mRNA molecules.
The market is highly competitive, with several players, including biopharmaceutical and pharmaceutical companies, research institutions, and government agencies, vying for a share of the growing market.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
170 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.93% |
|
Market growth 2024-2028 |
USD 776.45 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
4.34 |
|
Key countries |
US, Germany, UK, China, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this mrna synthesis raw material market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
